FDA Announces Plan to Reform Drug Approval, Hire Outside Experts To Handel Some Reviews
In Brief: Walter Lawrence, Reginald Ho Lead ACS; Henderson To Leave Dana-Farber for UCSF
NCI To Fund More Than 1,000 Competing Grants Under FY 1992 Budget
FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available
DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation
DCE Technical Support Contracts Recompetition Approved in Concept
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - The end of “more money, more people, more trials”
Cancer centers are being asked to grow their portfolios on flat budgets. Headcount is the wrong answer. - Harold Freeman, a surgeon who championed health equity, dies at 93
Freeman, the father of patient navigation, served as president of ACS and chair of the President’s Cancer Panel - Letai takes a swipe at “ill-informed commentators,” as he lays out his scientific vision for NCI
“To my knowledge, 100% of grants that clear my desk get funded” - Senthil K. Muthuswamy named director of NCI’s Center for Cancer Research
